DexCom, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 14 →Insiders1 insider bought $1.0M in 2 open-market buys. 6 insiders sold $4.0M, all 14 sales on a 10b5-1 plan.→PeersClosest companies: TNDM, BBNX, PFSA→
From the filings
Figures
- Revenue
- $4.97Blast 12 months
- Net income
- $999.7Mlast 12 months
- Operating cash flow
- $1.78Blast 12 months
- Cash and equivalents
- $1.10Bat the last balance sheet
- Shares outstanding
- 377.4M shareson issue